Visiomed Group SA

Equities

ALVMG

FR0013481835

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 11:35:03 2024-04-26 am EDT			5-day change	1st Jan Change
0.19 ^EUR	+3.26%		+0.21%	-32.86%

Mar. 26	Visiomed: share price rises on 'record' 2023 results	CF
Feb. 13	Visiomed: 38% increase in annual sales	CF

Ljv Capital signed an agreement to acquire Innoxa And T. Leclerc Brands and a stake in Phytosuisse Gmbh from Visiomed Group SA.

February 24, 2020

Ljv Capital signed an agreement to acquire Innoxa And T. Leclerc Brands and a stake in Phytosuisse Gmbh from Visiomed Group SA (ENXTPA:ALVMG) on February 25, 2020. The transaction expects to ensure immediate cash injection and reduce Visiomed Group's expenses. The transaction will be effective on February 29, 2020.

Latest news about Visiomed Group SA

Visiomed: share price rises on 'record' 2023 results	Mar. 26	CF
Visiomed: 38% increase in annual sales	Feb. 13	CF
Visiomed: new CEO appointed	Jan. 22	CF
Visiomed: expands activities in Saudi Arabia	Jan. 02	CF
Visiomed Group Secures Location for Plan to Build Medical Center in Saudi Arabia	Jan. 02	MT
Visiomed Group SA's Equity Buyback announced on April 17, 2023, has expired.	23-10-18	CI
Visiomed Group SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-09	CI
CAC40: ends the day in green despite bond tensions	23-08-21	CF
CAC40: rebound falters, rising interest rates cause concern	23-08-21	CF
CAC40: back above 7,200 despite glowing interest rates	23-08-21	CF
CAC40: starts the week in green, tops 7200 points	23-08-21	CF
Visiomed: share price rises sharply on resumption of trading	23-08-21	CF
CAC40: erases part of its losses before the close	23-08-18	CF
CAC40: decline confirmed, stagnates above 7100 pts	23-08-18	CF
CAC40: at 7100 points, the downturn deepens	23-08-18	CF
Visiomed: listing suspended	23-08-18	CF
VISIOMED : EuroLand Corporate initiates Buy coverage	23-06-08	CF
Visiomed Group SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Visiomed Commences EUR44 Million Share Repurchase Program	23-04-24	MT
Visiomed: launch of share buyback program, share price surges	23-04-18	CF
Visiomed Group SA announces an Equity Buyback for 29,435,641 shares, representing 10% for €44.15 million.	23-04-16	CI
Visiomed Group SA authorizes a Buyback Plan.	23-04-16	CI
Visiomed Group: 3rd digital medical center in Dubai	23-03-09	CF
Visiomed Group to Form Healthcare JV in Saudi Arabia	23-02-17	MT
Visiomed: partnership to establish a presence in Saudi Arabia	23-02-17	CF

Chart Visiomed Group SA

Duration

Period

More charts

Company Profile

Founded in 2007, Visiomed Group SA relies on a long experience to innovative healthcare technologies and services that will shape tomorrow's health and prevention. The Group now has focused its activities on the Middle East since 2021 with the acquisition of Smart Salem, the first digital medical analysis centre accredited by the Dubai Health Authority (DHA) in the United Arab Emirates, 100% owned by Visiomed Group SA. Visiomed Group SA is also stepping up its development in the region, with the creation of Smart Health, a joint venture which will drive the deployment of the group's innovative centers in Saudi Arabia.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
VISIOMED GROUP SA	-32.86%	59.69M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution